1 / 7

GFP

A. MSCV. MSCV. GFP-RV. 5 ‘ LTR. IRES. GFP. 3 ‘ LTR. 3 ‘ LTR. mIFN- . IRES. GFP. IFN/GFP-RV. 5 ‘ LTR. B. GFP-RV IFN/GFP-RV. 35%. 34%. 55%. 56%. CD 8. 2%. 2%. 8%. 8%. GFP. C. GFP-RV IFN/GFP-RV. 99%. 99%.

marcos
Download Presentation

GFP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A MSCV MSCV GFP-RV 5‘ LTR IRES GFP 3‘ LTR 3‘ LTR mIFN- IRES GFP IFN/GFP-RV 5‘ LTR B GFP-RV IFN/GFP-RV 35% 34% 55% 56% CD 8 2% 2% 8% 8% GFP C GFP-RV IFN/GFP-RV 99% 99% CD 8 GFP Becker et al., Fig.1

  2. 100 80 60 40 20 Fibroblasts IFN--/- CD8+cells A B 300 Tc1 Tc2 250 200 pg IFN-  / ml pg IFN-  / ml 150 100 50 0 0 -CD3 -CD3 -CD3 stimulation: infection: GFP-RV IFN/GFP-RV GFP-RV IFN/GFP-RV IFN/GFP-RV C D IFN-+/+ CD8+cells IFN-+/+ CD8+cells 1200 1000 1000 800 800 600 pg IFN-  / ml pg IFN-  / ml 600 400 400 200 200 0 0 -peptide-peptide -CD3 -CD3 stimulation: infection: GFP-RV IFN/GFP-RV GFP-RV IFN/GFP-RV Becker et al., Fig.2

  3. A Infection: IFN/GFP-RV Stimulation: unstimulated anti-CD3 Dilution: 1 1/3 1/9 1/27 -RT 1 1/3 1/9 1/27 -RT end. IFN viral IFN- total IFN GAPDH B Infection: GFP-RV Stimulation: unstimulated anti-CD3 Dilution: 1 1/3 1/9 1/27 -RT 1 1/3 1/9 1/27 -RT end. IFN viral IFN total IFN GAPDH C IFN/GFP-RV GFP-RV Unstimulated anti-CD3 IFN 67% 58% GFP Becker et al., Fig.3

  4. 2000 1800 1600 1400 pg IFN-  / ml 1200 1000 800 600 400 200 0 GFP- GFP + GFP - GFP + 4000 Tc1 day 8 day16 3500 3000 2500 pg IL-4 / ml 2000 1500 1000 500 n.d. n.d. n.d. n.d. 0 GFP- GFP + GFP - GFP + day 8 day16 IFN- 2000 Tc1 Tc2 1800 1600 1400 pg IFN-  / ml 1200 1000 800 600 400 200 0 GFP- GFP + GFP - GFP + day 8 day16 IL-4 4000 Tc2 3500 3000 2500 pg IL-4 / ml 2000 1500 1000 500 0 GFP- GFP + GFP - GFP + day 8 day16 Becker et al., Fig.4

  5. A B C GFP-RV GFP-RV 80000 70000 60000 50000 pg IFN- / ml V8.1, 8.2 IFN- IFN/GFP-RV IFN/GFP-RV 40000 30000 20000 10000 0 GFP GFP GFP-RV IFN/GFP-RV Becker et al., Fig.5

  6. Infection Stimulation pg IFN- / ml 1000 600 700 100 200 400 500 800 300 900 0 GFP-RV GFP + IL-12/IL-18 IL-12/IL-18 IFN/GFP-RV GFP - IFN/GFP-RV GFP + IL-12/IL-18 Becker et al., Fig.6

  7. IFN/GFP-RV + HA peptide GFP-RV + HA peptide IFN/GFP-RV GFP-RV 10 9 8 7 6 mm mean tumor diameter 5 4 3 2 1 0 0 5 10 15 20 25 30 Days after Challenge A 60 50 40 % specific lysis 30 20 10 0 0 10:1 1:1 5:1 E:T ratio B      Becker et al., Fig.7

More Related